Memory dysfunction in panic disorder: An investigation of the role of chronic benzodiazepine use

Depression and Anxiety

Volumn 28, Issue 11, 2011, Pages 999-1007

  Deckersbach, Thilo ^a   Moshier, Samantha J ^b   Tuschen Caffier, Brunna ^c   Otto, Michael W ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

anxiety disorders; anxiolytic; benzodiazepine; long term; memory; neuropsychological; psychopharmacology; short term; tests

Indexed keywords

ALPRAZOLAM; CLONAZEPAM;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPISODIC MEMORY; FEMALE; HUMAN; LONG TERM CARE; LONG TERM MEMORY; MALE; MEMORY DISORDER; PANIC; PRIORITY JOURNAL; SEMANTIC MEMORY; SHORT TERM MEMORY; TREATMENT OUTCOME; VERBAL MEMORY;

ADULT; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PANIC DISORDER; TIME FACTORS;

EID: 81255158572     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20891     Document Type: Article

References (67)

1. Cohen S,. A clinical appraisal of diazepam. Psychosomatics 1981; 22: 761-769. (Pubitemid 12242803)
2. Rickels K,. Use of antianxiety agents in anxious outpatients. Psychopharmacology (Berl) 1978; 58: 1-17. (Pubitemid 8356976)
3. Barbee JG,. Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. J Clin Psychiatry 1993; 54: 86-97. (Pubitemid 23358274)
4. Stewart SA,. The effects of benzodiazepines on cognition. J Clin Psychiatry 2005; 66: 9-13. (Pubitemid 40343675)
5. Bergman H, Borg S, Holm L,. Neuropsychological impairment and exclusive abuse of sedatives or hypnotics. Am J Psychiatry 1980; 137: 215-217. (Pubitemid 10143773)
6. Golombok S, Moodley P, Lader M,. Cognitive impairment in long-term benzodiazepine users. Psychol Med 1988; 18: 365-374.
7. Lucki I, Rickels K, Geller AM,. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berl) 1986; 88: 426-433. (Pubitemid 16109551)
8. Petursson H, Gudjonsson GH, Lader MH,. Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology (Berl) 1983; 81: 345-349. (Pubitemid 14209491)
9. Tonne U, Hiltunen AJ, Vikander B, et al. Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatr Scand 1995; 91: 299-304.
10. Barker MJ, Greenwood KM, Jackson M, Crowe SF,. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 2004; 19: 437-454. (Pubitemid 38373546)
11. Purcell R, Maruff P, Kyrios M, Pantelis C,. Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 1998; 55: 415-423. (Pubitemid 28237275)
12. Shin MS, Park SJ, Kim MS, et al. Deficits of organizational strategy and visual memory in obsessive-compulsive disorder. Neuropsychology 2004; 18: 665-672. (Pubitemid 39363152)
13. Yehuda R, Keefe RS, Harvey PD, et al. Learning and memory in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1995; 152: 137-139.
14. Boldrini M, Del Pace L, Placidi GP, et al. Selective cognitive deficits in obsessive-compulsive disorder compared to panic disorder with agoraphobia. Acta Psychiatr Scand 2005; 111: 150-158. (Pubitemid 40293183)
15. Asmundson GJ, Stein MB, Larsen DK, Walker JR,. Neurocognitive function in panic disorder and social phobia patients. Anxiety 1994; 1: 201-207.
16. Lucas JA, Rapaport MH,. 1993. Neurocognitive functioning in panic disorder and social phobia. The 13th National Conference of Anxiety Disorders Association of America. Charleston, SC.
17. Lucas JA, Telch MJ, Bigler ED,. Memory functioning in panic disorder: a neuropsychological perspective. J Anxiety Disord 1991; 5: 1-20.
18. Gladsjo JA, Rapaport MH, McKinney R, et al. A neuropsychological study of panic disorder: negative findings. J Affect Disord 1998; 49: 123-131. (Pubitemid 28202002)
19. Cowley DS, Roy-Byrne PP, Radant A, et al. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment. Neuropsychopharmacology 1995; 12: 147-157.
20. Bisaga A, Katz JL, Antonini A, et al. Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 1998; 155: 1178-1183. (Pubitemid 28402509)
21. Graeff FG, Del-Ben CM,. Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobehav Rev 2008; 32: 1326-1335.
22. Shioiri T, Kato T, Murashita J, et al. High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS. Biol Psychiatry 1996; 40: 785-793. (Pubitemid 26353973)
23. First MB, Spitzer RL, Gibbon M, Williams JB,. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. New York: New York Psychiatric Institute; 1995.
24. Brown TA, DiNardo PA, Barlow DH,. Anxiety Disorders Interview Schedule for DSM-IV. New York, NY: Graywind Publications, Inc.; 1994.
25. Guy W,. ECDEU Assessment Manual for Psychopharmacology, Revised Edition. Rockville, MD: NIMH; 1976.
26. Spielberger CD, Gorsuch RL, Lushene R, et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press; 1983.
27. Beck AT, Steer RA,. Beck Depression Inventory Manual. San Antonio, TX: Psychological Cooperation; 1986.
28. Michelson D, Lydiard RB, Pollack MH, et al. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry 1998; 155: 1570-1577. (Pubitemid 28512027)
29. Otto MW, Pollack MH, Penava SJ, Zucker BG,. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther 1999; 37: 763-770. (Pubitemid 29287281)
30. Pollack MH, Worthington 3rd JJ, Otto MW, et al. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull 1996; 32: 667-670.
31. Hill HE, Haertzen CA, Wolbach Jr AB, Miner EJ,. The addiction research center inventory: standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, Lsd-25, pyrahexyl and chlorpromazine. Psychopharmacologia 1963; 4: 167-183.
32. Martin WR, Sloan JW, Sapira JD, Jasinski DR,. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971; 12: 245-258.
33. de Wit H, Griffiths RR,. Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 1991; 28: 83-111.
34. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR,. The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21: 1-16. (Pubitemid 12093480)
35. Hermann DJ, Neisser U,. An inventory of everyday memory experiences. In:, Gruneberg MM, Morris PE, Sykes RN, editors. Practical Aspects of Memory. London, New York: Academic Press; 1978.
36. Wechsler D,. Wechsler Memory Scale-Revised Manual. San Antonio, TX: The Psychological Corporation; 1987.
37. Benton AL,. Benton Visual Retention Test Manual (5th ed.). San Antonio, TX: The Psychological Corporation; 1992.
38. Lezak MD,. Neuropsychological Assessment. Oxford, New York: Oxford University Press; 2004: xiv, 1016.
39. Vandenberg SG, Kuse AR,. Mental rotations, a group test of three-dimensional spatial visualization. Percept Mot Skills 1978; 47: 599-604. (Pubitemid 9057344)
40. Delis DC, Kramer JH, Kaplan E, Ober BA,. California Verbal Learning Test Research Edition Version Adult Manual. San Antonio, TX: The Psychological Corporation; 1987.
41. Osterrieth PA,. Le test de copie d'une figure complex: contribution à l'étude de la perception et de la memoire [The test of copying a complex figure: a contribution to the study of perception and memory]. Archives de Psychologie 1944; 30: 286-350.
42. Benton AL,. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968; 6: 53-60.
43. Benton AL, Jamsher Kd,. Multiligual Aphasia Examination. Iowa: AJA Associates; 1989.
44. Deckersbach T, Otto MW, Savage CR, et al. The relationship between semantic organization and memory in obsessive-compulsive disorder. Psychother Psychosom 2000; 69: 101-107. (Pubitemid 30084875)
45. Youngjohn JR, Crook 3rd TH,. Learning, forgetting, and retrieval of everyday material across the adult life span. J Clin Exp Neuropsychol 1993; 15: 447-460. (Pubitemid 23269846)
46. Castaneda AE, Tuulio-Henriksson A, Marttunen M, et al. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008; 106: 1-27. (Pubitemid 350309672)
47. Vasa RA, Roberson-Nay R, Klein RG, et al. Memory deficits in children with and at risk for anxiety disorders. Depress Anxiety 2007; 24: 85-94. (Pubitemid 46516664)
48. Mantella RC, Butters MA, Dew MA, et al. Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry 2007; 15: 673-679.
49. Savage CR, Baer L, Keuthen NJ, et al. Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry 1999; 45: 905-916. (Pubitemid 29185482)
50. Airaksinen E, Larsson M, Forsell Y,. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 2005; 39: 207-214. (Pubitemid 39602645)
51. Henin A, Savage CR, Rauch SL, et al. Is age at symptom onset associated with severity of memory impairment in adults with obsessive-compulsive disorder? Am J Psychiatry 2001; 158: 137-139. (Pubitemid 32047262)
52. Kuelz AK, Hohagen F, Voderholzer U,. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biol Psychol 2004; 65: 185-236. (Pubitemid 38152991)
53. Micco JA, Henin A, Biederman J, et al. Executive functioning in offspring at risk for depression and anxiety. Depress Anxiety 2009; 26: 780-790.
54. Colenda CC, Legault C, Rapp SR, et al. Psychiatric disorders and cognitive dysfunction among older, postmenopausal women: results from the Women's Health Initiative Memory Study. Am J Geriatr Psychiatry 2010; 18: 177-186.
55. Ma Q,. Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull 2008; 24: 265-270.
56. Maina G, Rosso G, Zanardini R, et al. Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: a case-control study. J Affect Disord 2010; 122: 174-178.
57. Minelli A, Zanardini R, Bonvicini C, et al. BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. Eur Arch Psychiatry Clin Neurosci 2011; 261: 323-329.
58. Strohle A, Stoy M, Graetz B, et al. Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 2010; 35: 364-368.
59. Airaksinen E, Larsson M, Lundberg I, Forsell Y,. Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med 2004; 34: 83-91. (Pubitemid 38139443)
60. Biringer E, Rongve A, Lund A,. A review of modern antidepressant' effects on neurocognitive function. Curr Psychiatry Rev 2009; 5: 164-174.
61. Veiel HO,. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 1997; 19: 587-603. (Pubitemid 27452012)
62. Vythilingam M, Vermetten E, Anderson GM, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 2004; 56: 101-112. (Pubitemid 38844785)
63. Goodwin GM,. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J Psychopharmacol 1997; 11: 115-122. (Pubitemid 27252642)
64. Cohen LJ, Hollander E, DeCaria CM, et al. Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects. J Neuropsychiatry Clin Neurosci 1996; 8: 82-85. (Pubitemid 26044705)
65. O'Toole MS, Pedersen AD,. A systematic review of neuropsychological performance in social anxiety disorder. Nord J Psychiatry 2011; 65: 147-161.
66. Zalewski C, Thompson W, Gottesman II,. Comparison of neuropsychological test performance in PTSD, generalized anxiety disorder, and control Vietnam veterans. Assessment 1994; 1: 133-142.
67. McHugh RK, Smits JA, Otto MW,. Empirically supported treatments for panic disorder. Psychiatr Clin North Am 2009; 32: 593-610.